Dr. Elewski disclosed that she has conducted clinical research for Novartis, Barrier Therapeutics, and Stiefel Laboratories.
Factors that have been identified to be associated with a bad prognosis for onychomycosis include dermatophytoma, thick nail, and a total dystrophic nail. Courtesy Dr. Boni E. Elewski